Guru Ownership Trend
Guru Analysis for Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (MYGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $38.83 M.
Top institutional holders include Larry Robbins and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $192,854.91 net inflow during the quarter.
Recent activity highlights Louis Moore Bacon who opened a new position. Conversely, Steven Cohen reduced exposure by 22.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Myriad Genetics, Inc. (MYGN)
Major holders include Larry Robbins ($24.35 M), Cliff Asness ($8.61 M), Ken Fisher ($5.36 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 10.19 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $192,854.91, with 5 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited MYGN. The total reported sell value was $5.03 M.
Yes, 1 managers opened new positions in MYGN, and 4 increased their existing holdings. The total reported buy value was $5.22 M.